BridgeMD
Compares treatment options for Pulpotomy
Official title Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars
ClinicalTrials.gov ID: NCT06640205
What this study is testing
- What it's testing
- Assessment of I-PRF versus Nano Mineral trioxide aggregate Combined with I-PRF in pulpotomy in mature Mandibular First Molars
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 30. Healthy volunteers may be eligible.
You may be able to join if
- Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.
- Patients of either gender aged from 15-30.
- Tooth should give positive response to cold test.
- The tooth is restorable
- Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
You likely can't join if
- Patients with immature roots.
- Haemostasias after 10 minutes can not be controlled after total pulpotomy
- Patients with periapical lesions or infections.
- Pregnant females.
- Patients with fistula or swelling
- Patients with necrotic pulp.
See the full eligibility criteria
- Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.
- Patients of either gender aged from 15-30.
- Tooth should give positive response to cold test.
- The tooth is restorable
- Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
- Patients who will agree to the consent and will commit to follow-up period.
- Patients with mature root.
- Patients with no internal or external resorption and no periapical lesions.
- Soft tissues around the tooth are normal with no swelling or sinus tract.
- Patients with immature roots.
- Haemostasias after 10 minutes can not be controlled after total pulpotomy
- Patients with periapical lesions or infections.
- Pregnant females.
- Patients with fistula or swelling
- Patients with necrotic pulp.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 30 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.